These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1202532)

  • 1. [Aspects of defibrinogenation therapy].
    Klüken N
    Phlebologie; 1975; 28(1):39-41. PubMed ID: 1202532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative effects of ancrod, urokinase and heparin on intraglomerular coagulation induced by progressive Masugi nephritis (author's transl)].
    Fujioka M
    Nihon Jinzo Gakkai Shi; 1980 Aug; 22(8):1113-24. PubMed ID: 7012408
    [No Abstract]   [Full Text] [Related]  

  • 3. Soluble fibrin complex production and proteolysis during ancrod therapy.
    McKillop C; Edgar W; Prentice CR; Forbes CD
    Scott Med J; 1975 May; 20(3):139-40. PubMed ID: 127379
    [No Abstract]   [Full Text] [Related]  

  • 4. Proceedings: Clinical improvement in peripheral circulation by controlled defibrinogenation.
    Dormandy JA; Goyle KB
    Br J Surg; 1976 Aug; 63(8):661-2. PubMed ID: 953495
    [No Abstract]   [Full Text] [Related]  

  • 5. Ancrod: clinical indications and methods of use.
    Wright JG; Geroulakos G
    Semin Vasc Surg; 1996 Dec; 9(4):315-28. PubMed ID: 8958608
    [No Abstract]   [Full Text] [Related]  

  • 6. Coagulation studies during therapeutic application of arvin.
    Vinazzer H
    Thromb Res; 1976 Feb; 8(2):243-8. PubMed ID: 943132
    [No Abstract]   [Full Text] [Related]  

  • 7. Ancrod: understanding the agent.
    Illig KA; Ouriel K
    Semin Vasc Surg; 1996 Dec; 9(4):303-14. PubMed ID: 8958607
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevention of deep vein thrombosis by subcutaneous ancrod.
    Lowe GD
    Scott Med J; 1978 Oct; 23(4):329-30. PubMed ID: 364647
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative effects of heparin, urokinase, and ancrod on intraglomerular coagulation induced in progressive Masugi nephritis.
    Dohi K; Fujioka M; Nakamoto Y
    Acta Pathol Jpn; 1982 Nov; 32(6):1047-52. PubMed ID: 6760667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible pathway for formation of fibrin degradation products during ancrod therapy.
    McKillop C; Edgar W; Forbes CD; Prentice CR
    Nature; 1975 Jun; 255(5510):638-40. PubMed ID: 1134556
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of defibrination on tumor growth and response to chemotherapy.
    DeWys WD; Kwaan HC; Bathina S
    Cancer Res; 1976 Oct; 36(10):3584-7. PubMed ID: 953985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo production of soluble complexes containing fibrinogen-fibrin related antigen during ancrod therapy.
    McKillop C; Edgar W; Forbes CD; Prentice CR
    Thromb Res; 1975 Sep; 7(3):361-72. PubMed ID: 1188838
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of experimental postoperative adhesions by ancrod defibrinogenation.
    Buckman RF; Bordos D; Bell WR; Cameron JL
    J Surg Res; 1975 Apr; 18(4):377-84. PubMed ID: 1142753
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of treatment with ancrod (Arwin) in 21 patients with chronic arterial occlusive disease].
    Rosendo A; Sala Planell E; Latorre J; Marinello J; Olba L; Rutllant ML
    Rev Clin Esp; 1982 Mar; 164(5):313-6. PubMed ID: 7100546
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic defibrinogenation as conservative therapy of peripheral arterial occlusive disease. A critical analysis].
    Ernst E
    MMW Munch Med Wochenschr; 1983 Sep; 125(37):796-8. PubMed ID: 6415441
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
    Wiles PG; Nelson SR; Hampton KK; Casali B; Boothby M; Prentice CR
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):385-8. PubMed ID: 2133215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Arvin--a new therapeutic agent].
    Ehrly AM
    Med Welt; 1978 Jul; 29(27-28):1144-5. PubMed ID: 672584
    [No Abstract]   [Full Text] [Related]  

  • 18. Ancrod: a practical alternative to heparin.
    Cole CW; Bormanis J
    J Vasc Surg; 1988 Jul; 8(1):59-63. PubMed ID: 3385879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic defibrinogenation in peripheral vascular disease.
    Ernst E
    Int Angiol; 1985; 4(3):373-7. PubMed ID: 3913715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation by ancrod for carbon dioxide removal by extracorporeal membrane lung in the dog.
    Sinclair ME; Reber G; Schweizer A; Dorrington KL; De Moerloose P; Bouvier CA; Gardaz JP
    J Thorac Cardiovasc Surg; 1989 Feb; 97(2):275-81. PubMed ID: 2492625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.